856906-36-0

Basic information

• Product Name: C₂₀H₂₀N₂O₅
• Synonyms: C₂₀H₂₀N₂O₅
• CAS NO: 856906-36-0
• Molecular Weight: 368.389
• Mol File: 856906-36-0.mol

Chemical Properties

• CAS DataBase Reference: C₂₀H₂₀N₂O₅(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₀H₂₀N₂O₅(856906-36-0)
• EPA Substance Registry System: C₂₀H₂₀N₂O₅(856906-36-0)

Safety Data

• Hazardous Substances Data: 856906-36-0(Hazardous Substances Data)

Upstream product

• 852821-15-9 C₂₆H₃₆N₂O₅Si 
• 852821-14-8 C₂₆H₃₆N₂O₆Si 
• 90109-84-5 C₆H₉BrN₂O 
• 852821-12-6 3-benzyloxy-5-dimethylaminomethylisoxazole 
• 123320-44-5 (3-(benzyloxy)isoxazol-5-yl)methanol 
• 367954-24-3 (1S,2R,3S,6R)-2,3-Dihydroxy-7-oxa-bicyclo[4.1.0]hept-4-ene-3-carboxylic acid 
• 32359-20-9 (1S,2R)-1,2-dihydroxycyclohexa-3,5-diene-1-carboxylic acid 
• 1253798-65-0 C₂₀H₂₀N₂O₅ 
• 870288-27-0 C₂₀H₂₂N₂O₅ 

Downstream Products

• 852821-06-8 (4aS,8aS,9S)-3-(benzyloxy)-4a-(tert-butyldimethylsilyloxy)-9-(dimethylamino)-8a,9-dihydronaphtho[2,3-d]isoxazole-4,5(4aH,8H)-dione 
• 64-75-5 tetracycline hydrochloride 
• 856906-37-1 C₂₆H₂₄N₂O₅S 
• 1253799-57-3 C₄₈H₅₈FN₃O₇Si 
• 1253799-30-2 C₄₉H₅₆FN₃O₇Si 
• 1253798-74-1 C₄₄H₅₁N₃O₇Si 

Relevant articles and documents

Process Research and Development of TP-808: A Key Intermediate for the Manufacture of Synthetic Tetracyclines

Process research, development, and manufacture of TP-808 (1), a key intermediate for the discovery and manufacture of tetracycline analogues, is described. The process used for the preparation of 1 avoids chromatographic purifications and has been substan

PENTACYCLINE DERIVATIVES FOR THE TREATMENT OF INFECTIONS

The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics. The modular synthesis of tetracyclines and tetracycline analogs described provides an efficient and enantioselective route to a variety of tetracycline analogs and polycyclines previously inaccessible via earlier tetra-cycline syntheses and semi-synthetic methods. These analogs may be used as anti-microbial agents or anti-pro liferative agents in the treatment of diseases of humans or other animals.

SYNTHESIS OF TETRACYCLINES AND INTERMEDIATES THERETO

The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics. The recent development of a modular synthesis of tetracycline analogs through a chiral enone intermediate has allowed for the efficient synthesis of novel tetracycline analogs never prepared before. The present invention provides more efficient routes for preparing the enone intermediate and allows for substituents at positions 4a, 5, 5a, and 12a of the tetracycline ring system.

SYNTHESIS OF TETRACYCLINES AND ANALOGUES THEREOF

The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics. The modular synthesis of tetracyclines and tetracycline analogs described provides an efficient and enantioselective route to a variety of tetracycline analogs and polycyclines previously inaccessible via earlier tetracycline syntheses and semi-synthetic methods. These analogs may be used as anti-microbial agents or anti-proliferative agents in the treatment of diseases of humans or other animals.